CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

Market Cap	42.71B
Revenue (ttm)	2.09B
Net Income (ttm)	-109.65M
Shares Out	1.39B
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	95.84
Dividend	0.02 (0.07%)
Ex-Dividend Date	May 29, 2025

Volume	14,052,740
Average Volume	11,761,713
Open	31.05
Previous Close	30.98
Day's Range	29.30 - 31.10
52-Week Range	22.02 - 63.31
Beta	0.19
RSI	34.82
Earnings Date	Mar 19, 2026

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 2,487
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765

Financial Performance

In 2024, SHE:300765's revenue was 1.98 billion, a decrease of -21.98% compared to the previous year's 2.54 billion. Earnings were 53.73 million, a decrease of -87.63%.